REUTERS - U.S. drugmaker Biogen Inc reported a quarterly loss compared with a year-ago profit on Thursday due to a hefty income tax charge for recent changes to the U.S. tax code.
The company paid $1.57 billion in income tax in the quarter.
Net loss attributable to Biogen was $297.4 million, or $1.40 per share, in the fourth quarter ended Dec. 31. The company had a profit of $649.2 million, or $2.99 per share, a year earlier.
Total revenue rose to $3.31 billion from $2.87 billion.
(Reporting by Tamara Mathias in Bengaluru; Editing by Arun Koyyur)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app